iSpecimen (ISPC) Short-term Investments (2023 - 2024)
iSpecimen (ISPC) posted quarterly Short-term Investments of $466493.0 for Q1 2024, down 93.57% year-over-year from $7.3 million in Q2 2023, and down 82.48% quarter-over-quarter from $2.7 million in Q4 2023.
iSpecimen (ISPC) Short-term Investments (2023 - 2024) Analysis & Trends
iSpecimen's Short-term Investments history runs 2 years deep, the most recent figure standing at $466493.0 for Q1 2024.
- In Q1 2024, Short-term Investments fell 93.57% year-over-year to $466493.0; the TTM figure through Mar 2024 stood at $466493.0 (down 93.57% YoY), while the FY2023 annual figure was $2.7 million, changed N/A from the prior year.
- Short-term Investments for Q1 2024 stood at $466493.0, down from $2.7 million in the prior quarter.
- The five-year high for Short-term Investments was $7.3 million in Q1 2023, with the low at $466493.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | iSpecimen | 692,995.30 | -2.13 Mn | 71,599.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 466,493.00 |
| Dec 31, 2023 | 2.66 Mn |
| Sep 30, 2023 | 2.94 Mn |
| Jun 30, 2023 | 6.21 Mn |
| Mar 31, 2023 | 7.26 Mn |